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THE HUMAN ERYTHROCYTE MEMBRANE 
Human erythrocyte memtirane is probably the best understood among 
the biological membranes in view of its easy availability/ ease of prepa-
ration and characterization. It has long served as a convenient model for 
the testing of new concepts and methodologies in membrane biochemistry. 
The erythrocyte membrane is composed of about equal amounts of lip-
ids and proteins. The carbohydrate components of the red blood cell (rbc) 
membrane are confined to the exterior surface as oligosaccharide moieties 
of glycolipids and glycoproteins (Sweeley and Dawson, 1969). They are for 
the most pact, responsible for the surface charge and surface determinant 
properties. It is well known that the rbcs have a large negative charge 
at their outer surface (Cook et al./ 1961). Carboxyl groups of the sialic 
acid residues which are associated with the major rbc membrane glycoprot-
eins/are responsible for most of the negative charge (Eylar et al./1962). 
Tne rbc membrane lipid composition is rather complex due to the occu-
cance of several variants/both in polar and non-polar moieties of the mo-
lecule. The amount of total lipids in lO-'-'^  cells is about 5 mg which is 
comprised of about 30 % neutral lipids,60 % phospholipids and 10 % glyco-
lipids (Cooper, 1969). Free cholesterol constitutes the major component 
of tne neutral lipids in rbc. It is randomly distributed and present 
throughout the thickness of the rbc membrane (Higgins et al.,1973). Quan-
titatively, the most important fractions of human rbc lipids are the pho-
spholipids or phosphatides. The phospholipids include glycero- and 
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sphingo-phosphoiipids. Lecithins/ cephalins/phosphatidylserine and sphin-
gomyelins are the four main subclasses of phospholipids. Human rbc membr-
ane contains about 20 % sphingomyelin and 35 % phosphatidylcholine 
(White/ 1973). Glycolipids constitute about 5 - 10 % by weight of the to-
tal lipids. 
The first systennatic separation of rbc membrane proteins was descr-
ibed by Fairbanks et al. (1971). These workers have designated the vari-
ous polypeptide components by numbers/ according to their mobility in po-
lyacrylaunide gels in presence of SDS. This nomenclature is now widely 
accepted. 
Extensive literature is available on the nature and function of the 
principal polypeptides of the human erythrocyte membrane (Juliano/ 1973; 
Haest/1982;Bennett/1985). Only a brief summary of the information on the-
se polypeptides is presented below 
Band 1 and 2 (Spectrin)- Spectrin is the major component of the human 
rbcs membrane extrinsic proteins and occurs as a stable dimer of two si-
milar yet chemically distinct polypeptides. The two polypeptides/ band 1 
(240 Kda) and band 2 (220 Kda)/ are oriented as parallel and intertwis-
ted chains (Marchesi,1979). Spectrin is believed to be atleast tetrameric 
and the association of dimers occurs end to end in situ (Morrow and 
Marchesi/ 1981). 
Band 2.1/ 2.2 and 2.3 (Ankyrin)- Band 2.1 of 210 Kda connects band 2 of 
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membrane skeleton with band 3 of intrinsic domain (Morrow et al./ 1980) 
and in situ it is found in the monomeric form(Bennett and Stenbuck,1980). 
Not much is known about the structure and associations of other ankyrin 
polypeptides corresponding to bands 2.2 (183 Kda) and 2.3 (105 Kda) 
(Siegel et al., 1980). 
Band 3- Band 3 is the major intrinsic protein constituting about 50-60 % 
of the total intrinsic proteins. It is an inorganic anion transporting 
protein of 95 Kda (Cabantchik et al., 1975) and is believed to exist as 
dimers and to some extent as tetramers in the membrane (Nakashima et al., 
1981). This protein traverses the rbc membrane and has an outer glycosy-
lated domain and an intracellular domain, which is not glycosylated. 
Band 4.1- The band 4.1, protein of 78 Kda, is involved in the interaction 
of spectrin with actin (Wolfe et al./ 1980). The band 4.1 is a globular 
molecule of 6 nm diameter (Tyler et al., 1979). Each spectrin dimer has 
one binding site for band 4.1 located at the free end of dimer-dimer com-
plex (Tyler et al., 1979). 
Band 4.2- This is an intrinsic protein of unknown function consisting of 
a 4 X 72 Kda unit. The band 4.2 polypeptides remain associated with the 
cytoplasmic region of band 3. (Land and Nermut, 1980). 
Band 4.9- Further putative component of membrane skeleton is the band 4.9 
of 48 Kda. Oxidative treatment of cells results in cross-linking of band 
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4.9 wich Dand 2 via disulfide bonds indicating the in situ proximity of 
the Dand (Liu and Palek/ 1979). 
Band 5- Band 5 polypeptide is also called actin. It is a component of the 
membrane skeleton and forms short oligomers containing about 10 molecules 
in filamentous form (Brenner and Korn/ 1980). Each spectrin tetramer has 
two actin binding sites at the free end. This protein has been shown to 
play a major role in the shape change of rbcs. 
Band 6- This is a monomer of glyceraldehyde-3-phosphate dehydrogenase. 
The enzyme is a tetramer of 35 Kda and binds to spectrin-actin complex as 
well as to band 3 (Yeltman and Harris, 1980; Murthy et al., 1981). 
Band 1- Band 7 protein of 29 Kda has not yet been fully characterized and 
it is also not very clear as to where and how it is arranged in the eryt-
hrocyte membrane. The phosphatidyl serine transporter protein of human 
erythrocyte membrane has been shown to comigrate with the band 7 protein 
(Connor and Schroit/ 1988). 
The human rbc membrane is decorated at the cytoplasmic surface with 
a densely packed spectrin-actin skeleton. From microscopic pictures and 
calculations it can be derived that the membrane skeleton covers 50-70 % 
of the membrane surface. The membrane skeleton was originally defined as 
the protein filamentous matrix of the same dimensions as the originating 
ghost that remains after extraction of the lipids and intrinsic proteins 
from intact erythrocytes or ghosts using Triton X-100 (Yu et al., 1973). 
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Subsequent/purification of the skeleton gave a lipid-poor (1-2 %) protein 
band containing besides spectrin (bands 1 and 2) a number of peptides and 
band 5 (SheetZ/ 1979). This composition represents the minimal number of 
bands necessary to maintain stability of the skeleton. Stabilization of 
the skeleton components within the network probably occurs via non-coval-
ent bonds of varying affinity as well as by electrostatic repulsions of 
negatively charged spectrin molecules. 
Although the membrane skeleton highly restricts lateral mobility of 
intrinsic proteins/ cytoskeleton is a highly shear deformeable lattice. 
Shear deformability of this lattice is evidenced by the extreme deformat-
ions of the cell in circulation as well as by deformations induced by 
drugs and other substances. The membrane skeleton can be viewed as being 
constructed around spectrin. Spectrin tetramers are involved in two inde-
pedent classes of protein associations that are both essential for the 
final structure for (a) formation of the two dimensional meshwork under-
lying the lipid bilayer/ by associations with actin oligomers/ band 4.1 
and possibly other spectrin molecules and (b) linkage of the spectrin/ 
actin meshwork to integral membrane proteins via association with ankyrin 
and possibly band 4.1 (Fig.I). 
Assembly of a meshwork requires some type of polymerization reacti-
on leading to branched structures. A frequently discussed arrangement of 
proteins (Cohen et al./ 1980; Brenner and Kocn, 1980; Pinder and Gratzer 
1983; Shen et al., 1984) involves a basic structural unit composed of 
actin filaments/ containing 12-17 actin monomers and accessory proteins 
such as band 4.9 and tropomyosin/Which are attached at the ends of multi-
ple spectrin tetramer/band 4.1 complexes (Fig.I). These actin-spectrin 
Fig. I. Schematic model of the human erythrocyte membrane 
skeleton. The barbed end of the actin filament is 
the fast-growing end while the pointed end is the 
slow-growing end. 
GLC A 
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complexes can then assemble to form a branching polymeric structure by 
interconnections between the free ends of spectrin tetramers and other 
actin oligomers. It has also been proposed that self-assembly of spectrin 
into hexamers and higher order oligomers from erythrocyte membranes init-
iate polymerization of G-actin by a cytochalasin inhibitable reaction and 
thus these actin filaments have free fast-growing ends (Lin and Lin/ 
1979; Brenner and Korn, 1980; Pinder and Gratzer, 1983; Shen et al., 
1984). In cells such as the developing erythrocytes and other tissues 
with related forms of spectrin/ the spectrin-actin meshwork could have 
extended actin filaments cross-linked along their length by spectrin or 
other actin-binding proteins to form three dimensional structures. Presu-
mably/ during erythrocytes maturation/actin in excess of the final 5 x 105 
copies per cell is lost/ perhaps as the consequence of a band 4.1 severi-
ng activity (Pinder et al./1984) and the red cell is left with a shell of 
short actin filaments adjacent to the membrane. 
MEMBRANE PROTEINS IN ABNORMAL ERYTHROCYTES 
Studies with hereditary hemolytic anemias in human and mice have in-
troduced the beginings of genetics in the area of membrane skeletal pro-
teins. It has been clearly demonstrated that abnormal or deficient mem-
brane proteins lead to major defects in erythrocyte shape and mechanical 
stability. Hereditary spherocytosis and elliptocytosis are relatively 
common (approximately 1;5000) disorders of the erythrocyte membrane lea-
ding to fragile and/or abnormally shaped cells (Lux 1979; 1983; Palex and 
Lux, 1983). Erythrocytes accumulated in the spleen in both cases and 
anemia can be essentially cured by splenectomy. Hereditary spherocytosis 
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is in about 80 % of the cases transmitted as an autosomal dominant trait/ 
while hereditary elliptocytosis is almost entirely autosomal dominant. 
These diseases were recognized initially on the basis of abnormally appe-
aring erythrocytes/ associated with varying degrees of anemia/ that could 
not be explained by altered hemoglobin, glycolytic enzymes or autoimmune 
features. A distinctive feature of the spherocytosis group is that these 
ceils are more susceptible to hypotonic lysis/ presumably, due to a dec-
reased surface area/volume ratio. 
Pyropoikilocytosis is a rare recessively inherited variant of here-
ditary elliptocytosis and is characterized by erythrocytes that fragment 
and attain bizarre shapes after warming to 45-46 deg C which is about 4 
deg less than the disintegration temperature for noriral erythrocytes 
(Chang et al./ 1979). Spectrin isolated from these cells denatures at the 
same temperature of 45-46 deg C based on change in the ORD spectrum/ whi-
le normal spectrin denatures at 49-51 deg C. Spectrin from patients with 
pyropoikilocytosis also has a lowered affinity for the dimer-tetramer eq-
uilibrium (Liu et al., 1981; Knowles et al., 1983). It is likely that a 
change in spectrin amino acid sequence is responsible for these features/ 
since an altered tryptic cleavage has been detected in an 80/000 
Mr domain of the alpha chain (the portion of the molecule involved in 
dimer self-association,with the adjacent beta chain).A similar defect has 
also been observed in some patients with mild hereditary elliptocytosis 
(Liu et al./ 1982; Coetzer and Zail, 1982; Evans et al., 1983). 
High affinity ankyrin binding sites are reduced by 50% in erythrocyte 
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memoranes in two families with an elliptocytosis type anemia (Agre 
at ai./ 1981}. The cytoplasmic domain of band 3 purified from the defect-
ive membranes binds to ankyrin normally. These erythrocytes may have an 
altered arrangement of band 3 molecules rather than a defect in the bind-
ing site itself. 
It is also possible that spectrin binding defects play a role in he-
molysis in other forms of anemia. The binding of ankycin to spectrin is 
sensitive to alkylation of a sulfhydryl group on ankyrin (Bennett and 
Stenbuck/1980).It is possible that metabolic disorders such as glucose-6-
phosphate dehydrogenase deficiency/ which leads to lowered levels of red-
uced glutathione/ could result in the oxidation of ankyrin sulfhydryl 
groups. The ability of ankyrin to bind to spectrin would be compromised 
and possibly result in increased erythrocyte fragility. 
Another mechanism for the disease is the absence or decreased quanti-
ty of these proteins due to abnormal synthesis or instability of the pro-
duct. The first example of deficient proteins came from the strains of mu-
tant mice that were developed at the Jackson Laboratory (Russell/ 1979; 
Bernstein/ 1980). SDS-gels of ghosts membranes from these strains revea-
led a striking decrease in the quantity of spectrin/ and the extent of 
deficiency correlated with severity of the anemia (Greenquist et al., 
1978; Lux et al./ 1979). 
Decreased spectrin results from different mechanisms,depending on the 
strain of mouse (Bodine et al./1984). One mutant (nb/nb) produced no sta-
Dle ankyrin/ but did synthesize normal amounts of spectrin. Thus spectrin 
deficiency in no/nb mice is secondary to lack of ankyrin.These mice still 
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nave some membrane associated spectrin,indicating some spectrin/actin me-
shwork assembly and/or membrane associations of spectrin can occur in the 
absence of ankyrin.Another strain (ja/ja) lacks the ability to synthesize 
beta subunit of spectrin, although spectrin alpha chain mRNA was present 
in elevated amounts.Lack of the beta subunit,which has the ankyrin bindi-
ng site, thus prevents assembly of the spectrin/actin meshwork since act-
in-binding requires the presence of both subunits (Calvent et al., 1980; 
Cohen and Langley, 1984). 
Examples of markedly deficient protein 4.1 and spectrin have also been 
reported in some human hemolytic anemias. A form of elliptocytosis with 
abnormal erythrocyte morphology and increased fragility has been associa-
ted with lack of band 4.1 (Mueller and Morrison, 1981; 'Ithernia et al., 
1981). The parents had 50 % of the normal complement of band 4.1 and were 
asymptomatic with mildly abnormal erythrocytes. The affected individuals 
had a complete absence of band 4.1. It is not clear whether band 4.1 is 
lacking due to ineffective synthesis,abnormal degradation,decreased asso-
ciation with membranes,or if band 4.1 is present but is of different mol-
ecular weight. 
The amount of reduction in spectrin in patients with spherocytosis co-
rrelated closely with severity of the disease and with the reduction in 
membrane stability measured by the osmotic fragility assay, while other 
membrane proteins were essentially unchanged.Patients with a 10-20% spec-
trin deficiency have a mild, compensated anemia that may be subclinical, 
while patients with 20-40 % reduction in spectrin are moderately to seve-
rely anemic,usually require splenectomy and are detected in children. The 
-11-
molecular basis for spectrin deficiencies is likely to be diverse and by 
analogy with the mutant mice fall into two major categories/ (a) Unstable 
spectrin due to a defect in assembly or intrinsic susceptibility to prot-
ease and (b) Lowered synthesis of spectrin due to problems with mRNA syn-
thesis or stability. 
UNSTABLE HEMOGLOBINS 
Structural abnormalities of the hemoglobin molecule may result in 
instability through a number of different mechanisms and are a rare cause 
of congenital hemolytic anemia. In many instances instability leads to 
denaturation and precipitation of the abnormal hemoglobin within the 
cell/producing amorphous inclusions known as Heinz bodies (Table 1). The-
se attach themselves to the inner surface of the rbc membrane making the 
cells less flexible and impede their passage through microcirculation. 
Heinz bodies are much more numerous after splenectomy and it is likely 
that ceils are normally hindered in the spleen where Heinz bodies can be 
snipped out by the splenic macrophages or the cells can be removed alto-
gether. 
In most instances the hemoglobin instability results from a single or 
small number of amino acid substitutions in a critical area of the molec-
ule/ for example/ at a heme binding site or at a point of contact between 
individual globin chains (Table 2). 
The clinical features of an unstable hemoglobin disorder are of a he-
molytic anemia with splenomegaly. Exacerabation may occur during infec-
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Table 1. Mechanism and Effect of Heinz Body Focmation 
(White and Dacie, 1971) 
Postulated pathway In vitro observation 
Access of water to heme/ genera-
tion of H02 radical and H O . 
Oxidation of F9 cysteines and GSH. 
GSH binds onto F9 cysteins. 
Abnormal chains loose heme. 
Dissociations of tetramer into 
beta and alpha monomersi precipi-
tation of abnormal chain (Heinz 
Body). 
Heinz body binds to membrane 
sulfhydryl groups. 
Rigid membrane and abnormal memb-
rane function. 
Splenic sequestration and phagoc-
ytosis of Heinz body containing 
cell. 
Removal of Heinz bodies by spleen 
from cells sustaining minor damage 
without destruction of rbcs. Remo-
ovai by sequestration and phagocy-
tosis in reticuloendothelial syst-
em generally of red cells sustain-
ing major damage. 
Generation of methemoglobin. 
Low GSH, blockade of Hb, sulfhydryl 
groups. 
Stimulation of HMP shunt. 
Free heme catabolized to dipyrroles. 
Free soluble alpha chain monomers in 
lysatea. 
Reduction in titrable membrane sulfhy-
dryl groups. 
Increased cation permeability. 
Electron micrographic evidence. 
rbcs have low hemoglobin concentra-
tion/ also the unstable hemoglobin are 
synthesized in amounts greater than can 
be detected in the peripheral blood; 
Heinz bodies seen only after splenec-
tomy. 
GSH Reduced Glutathione 
HMP Hexose monophosphate shunt pathway 
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Table 2. Some Naturally CX:curing Unstable Hemoglobins 
Name Substitution Helical Abnormality Reference 
site 
Beta Chain 
Boras 
Bristol 
Freiburg 
Genova 
Gun Hill 
Hammersmith 
Variants 
Leu Arg 
Val Asp 
Val deleted 
Leu Pro 
Deletion of 5 
amino acids on 
F and FG helix. 
Phe Ser 
F4 
Ell 
B5 
BIO 
• • 
GDI 
Heme contact 
Heme contact 
Deletion 
Pro breaks 
alpha helix 
Deletion 
Heme contact 
Steadman et al. 
(1970) 
Hollender et al. 
(1969) 
Steadman et al. 
(1970) 
Jonea et al. (1966) 
Sansone et al.(1967) 
Bradley et al.(1967) 
White & Dacie (1971) 
Koln 
Leiden 
Olmsted 
Philly 
Val Met 
Glu acid deleted 
Leu Arg 
Tyr Phe 
D,3cie et al. (1967) 
Huehns (1970) 
Grimes et al. (1964) 
FG5 Heme contact Carrell et al.(1966) 
A3 or A4 Deletion De Jong et al.(1968) 
Riverdale Bronx Gly Arg 
Sabine Leu Pro 
H19 
CI 
B6 
F7 
Non polar 
polar 
Lorkin and Lehmann 
(1970) 
Weakens alp- Rieder et al.(1969) 
ha 1 beta 1 
contact 
Non polar Rannay et al. (1968) 
polar Zalusky et al.(1970) 
Heme contact Opfell et al. (1968) 
Pro breaks 
F helix. 
.. contd. 
Table II (contd.) 
Name Substitution 
Santa Ana 
Seattle 
Leu Pro 
Ala Glu 
Zurich His Arg 
Alpha chain variants 
Ann Arbor 
Bibba 
Dakar 
Etobicoke 
L-Ferrara 
Hasharon 
Leu Arg 
Leu Pro 
His 
Ser Arg 
Asp 
Asp 
Gly 
His 
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Helicai Abnormality Reference 
site 
F4 Heme contact Opfell et al. (1968) 
Pro breaks 
F helix 
E20 
Shepherds 
Sogn 
Sydney 
Tacoma 
Toulouse 
Wien 
Bush Gly Asp 
Leu Arg 
Val Ala 
Arg Ser 
Lys Glu 
Tyr Asp 
E18 
All 
Ell 
B12 
ElO 
H8 
E7 
Fl 
H19 
- Gly G19 
F5 
CDS 
CDS 
Glu intera- Huehns et al. (1970) 
cts with 
His EFl. 
Non-polar- White et al. (1970) 
polar 
Non polar Monn et al. (1968) 
polar 
Heme contact Carrell et al.(1967) 
weakens alp- Perutz and Lehmann/ 
hal betal (1968) 
contact 
Heme Contact Rosa et al. (1969) 
Non polar Perutz and Lehmann 
polar (1968) 
Heme Contact Huehns (1970) 
Non polar Rucknagel et al. 
polar (1968) 
Pro breaks 
H helix. 
Stabilizes 
G and B 
helices 
Non polar 
polar 
Unknown 
Unknown 
Kleihauer et al. 
(1968). 
Rosa et al. (1968) 
Crookston et al. 
(1969) 
Huehns (1970) 
Charache et al. 
(1967) 
Torino Phe Val CDl Heme contact Beretta et al.(1968) 
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tion in association with oxidant drugs such as sulfonamides^ nitrofuran-
toin or nalidixic acid/ as the unstable hemoglobin is particularly sensi-
tive to oxidant stress and hemoglobinuria may occur. The diagnosis of an 
unstable hemoglobin may be difficult* especially if the defect is mild. 
The most characteristic finding is an abnormal heat stability pattern: 
heating a dilute solution of hemoglobin to 50 deg C for 15 min. causes 
most of the unstable hemoglobin to precipitate.Hemoglobin electrophoresis 
may be useful but will be normal if the substitutions involve no change/ 
in the overall charge of the molecule (Bunch/ 1985). 
EFFECT OF PHENYLHYDRAZINE 
A number of hemolytic agents induce non-indegenous redox processes in 
erythrocytes. These drugs lower the circulating rbc population in suscep-
tible individuals by reducing their life span and also cause membrane de-
formabilty (Clark et al./1983). Persons with genetic deficiencies in key 
enzymes viz.glucose-6-phosphate dehydrogenase/glutathione reductase/ etc. 
that are involved in red cell metabolism are particularly susceptible to 
the induction of hemolytic anemia by these redox drugs. Of these agents/ 
phenylhydrazine (PHZ) is well known and has been subjected to a large 
number of investigations. 
PHZ is a potent redox active drug that can induce hemolytic anemia ev-
en in individuals without any erythrocytic enzyme deficiency (Beutler/ 
1969). Observations in the last century indicated that PHZ could induce 
dramatic changes in erythrocytes both in vitro as well as in vivo. 
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Hoppe-Seyier (1885) reported that blood from rabbits treated with PHZ was 
brown in colour and that addition of PHZ to the suspended erythrocytes 
gave them also a brown colouration. Subsequently, Heinz (1890) found that 
mixing either nucleated (from cold-blooded animals) or non-nucleated ery-
throcytes with PHZ turned them green-brown. Heinz (1890) also discovered 
that inclusion bodies were formed in erythrocytes exposed to PHZ. 
The hemolytic effects of PHZ, a reducing agent/may thus be viewed as 
a consequence of its autoxidation and the subsequent oxidation of the es-
sential sulfhydryl groups of enzymes and membrane proteins. The cellular 
and chemical responses of the rbcs to this agent have been thoroughly in-
vestigated. Oxyhemoglobin forms methemoglobin by PHZ induced processes 
and the reduction of methemoglobin to deoxyhemoglobin (in anaerobic sys-
tems) or the formation of Hb02 (in aerobic environments) can also be 
induced to occur. The oxidation of PHZ leads to the formation of a number 
of products including benzene (Beaven and White, 1954), hydrogen peroxide 
(Cohen and Hochstein, 1964), superoxide anion (Goldberg and Stern, 1975) 
and phenyl radicals (Hill and Thornalley, 1981). Some other species susp-
ected of being involved in the reaction of hemoglobin with PHZ include 
phenyldiazene (Beaven and White, 1954) and phenylhydrazyl ( Mishra and 
Fridovich,1976 ). It has also been reported that oxyhemoglobin and myogl-
obin react with PHZ to yield a derivative of hemoglobin containing N-
phenylprotoporphyrin in which the heme group is modified. Moreover, the 
identification of phenyliron (III) porphyrins in PHZ modified metmyoglo-
bin has supported the elucidation of the mechanism of hemoglobin modifi-
cation. 
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PHZ is readily permeable across the rtac membrane and has been shown 
to cause a number of effects. Thus its administration in vivo may lead to 
the production and accumulation of hydrogen peroxide in amounts above the 
detoxifying capacity of cellular protective mechanism (Cohen and Hochst-
ein 1961; 1965). Additionally/ PH2 has been shown to generate superoxide 
(Valenzuela et al./ 1977; Mishra and Fridovich/ 1976; Jain and Hochstein, 
1979)/ hydroxyl radicals (Mishra and Fridovich/ 1976) and phenylradicals 
(Goldberg and Stern/ 1977). The cytotoxicity of PHZ need not necessarily 
involve phenylradicals since hydrazine itself has effects on erythrocytes 
similar to those produced by PHZ (Jain and Hochstein/1979). Itano et al. 
(1975/ 1976) have further suggested that the formation of ferrichrome/ a 
product of phenyldiazene and ferrihemoglobin interaction may be involved 
in PHZ induced hemolysis. 
Jain and Hochstein (1980) have suggested that none of the factors 
associated with intracellular oxidative alterations e.g. glutathione/ 
methemoglobin/ Heinz bodies and hemichrome are altered in cells exposed 
to PHZ in vivo.The lack of such changes suggests that intracellular pero-
xide detoxifying mechanisms are functioning adequately in these cells de-
spite their shorter life spans. 
Spectrin is a major protein constituent of erythrocyte membranes and 
is presumably involved as a determinant of cell shape and deformability 
(Singer/1974;Greenquist and Shohet/1975). A decrease in the membrane con-
tent of spectrin and an increase in high molecular weight proteins and in 
the polymerized products of lipid peroxidation/ might well be expected to 
\ 
' ' ,0.':/A.//^. 
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dlcer cne rigidity and the life span of the affected cells (Heusinkveid 
et ai./1977; Dobretsov et al./ 1977). PHZ localized at membrane sites un-
dergoes autoxidation to form species capable of initiating lipid peroxi-
dation. The membrane changes which follow might form the basis for enhan-
ced sequestration and decreased survival of even reticulocytes which exh-
ibit no intracellular oxidative damage (Jain and Hochstein/ 1980). 
II. MATERIALS AND METHODS 
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Most of the chemicals used in the present studies were obtained 
from various sources as shown below. Other chemicals and reagents used 
were of analytical grade or the best grade available commercially. Glass 
distilled water was used in all the experiments. 
CHEMICALS SOURCES 
Acrylamide 
Ammonium persulphate 
Bovine serum albunin 
Coomassie brilliant blue R-250 
DithioDis (2-nitro benzoic acid) 
Ethylene diamine tetraacetate 
Giutatnione 
lodoacetate 
Beta-Mercaptoethanol 
N/N'-Methylene bisacrylamide 
1/10,Ortho-phenanthroline 
Pnenylhydrazine 
Pyronin Y. 
Sodium dodecyl sulfate 
N/N/N'/N'-Tetramethylethylene diamine 
Tris {hydroxymethyl) amino methane.HCl 
Sigma Chemical Co., U.S.A. 
May & Baker Ltd., England 
Sigma Chemical Co., U.S.A. 
Sigma Chemical Co., U.S.A. 
Sigma Chemical Co., U.S.A. 
B.D.H., India 
Biogen, India 
Sigma Chemical Co., U.S.A. 
Sigma Chemical Co., U.S.A. 
B.D.H., India 
E. Merck, India 
Riedel-de Haen Ag, W.Germany 
Sigma Chemical Co., U.S.A. 
Sigma Chemical Co., U.S.A. 
B.D.H., India 
Sigma Chemical Co., U.S.A. 
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Preparation of Erythrocyte Ghosts: Outdated human blood obtained from the 
local blood bank was used. Ghosts were prepared by the method of Fairba-
nks et al. (1971} which in turn is based on the principle of hypotonic 
lysis described by Dodge et al. (1963).25 ml of blood was diluted with an 
equal volume of cold 0.9% NaCl. The suspension was spun at 100 g for 10 
min. at 37 deg C and the supernatant and 'buffy coats' were aspirated. 
The packed cells were washed three times in 0.9% NaCl. 1 ml of the washed 
cells were hemolysed by mixing them rapidly with 40 ml of cold 5 mM Tris-
HCl buffer pH 7.4. The suspension was centrifuged at 12,000 g for 30 rain, 
at 4 deg C, The resultant deep red supernatant was aspirated leaving the 
red translucent pellet of packed ghosts over minute opaque crecim coloured 
"buttons". Removal of the latter at this stage was essential for minimi-
zing contamination of ghosts with proteases. Each centrifuge tube was 
tilted and rotated to allow the loose ghost pellet to slide off the 
tightly packed button which could be then aspirated with little loss of 
ghosts. The preparation obtained after few additional washes was used. 
For electrophoresis the ghosts were dissolved in a solution containing 
1 % SDS, 5-10 % sucrose/10 mM Tris HCl (pH 8),1 mM EDTA (pH 8)/and 10 ul/ 
ml of Pyronin Y (tracking dye). 
Polyacrylamide Gel Electrophoresis; The overall approach was that of Fa-
irbanks et al.(1971) with slight modification. For gel polymerization the 
alternative procedure of Davis et al. (1964) was followed. Compositions 
for stock solutions/ buffers and gels are as follows. 
- 2 1 -
A. Stock solutions 
Con AcBis 
Acrylamide (40 g) 
Bis (1.5 g) 
H O to 100 ml 
2 
20 % (w/w) SDS 
1.5 % (w/v) aimionium persulfate 
0.5 % (v/vj TEMED 
10 X Buffer (pH 7.4) 
1.0 M Tris 40 ml 
2.0 M Sodium acetate (10 ml) 
0.2 M EDTA (10 ml) 
Acetic acid (pH 7.4) 
H O to 100 ml 
B. Electrophoresis buffer (per liter) 
10 X Buffer (100 ml) 
20 % SDS (10 ml) 
H O (890 ml) 
C. Gels (per 40 mi of solution 5.6 % in acrylamide) 
Con. AcBis (5.6 ml) 
10 X buffer (4.0 ml) 
20 % SDS (4.0 ml) 
H O (20.4 ml) 
1.5 % ammonium persulfate (4.0 ml) prepared freshly at the time of 
use. 
0.5 % TEMED (2.0 ml) 
Concentrated stock solution was added in the proportions given in C and 
this was added to 9 cm long glass tubes of 6 mm diameter that were 
previously cleaned by washing with hot SDS. Each column (height 85 mm) 
was overlaid gently with 20 ul distilled water. When polymerization was 
complete the top of the gels were overlaid with about 0.5 ml of 
electrophoresis buffer. The gels were left to stand for atleast 12 hrs. 
Electrophoresis was performed with a current of 4 mA/tube. The tubes were 
removed from the electrophoresis apparatus as the tracking dye bands rea-
ched 75 mm mark from their origin. 
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The gdls were stained for protein with coomassie brilliant blue R-250 
(Fairbanks et al., 1971). They were placed in glass test tubes (height 15 
cm and diameter 1.5 cm) to which were added/ the fixing/Staining and des-
taining solutions. The solutions were kept overnight at 37 deg C or at 
room temperature in a solution of 0.025 % coomassie brilliant blue R-250 
in 25 % isopropyl alcohol and 10 % glacial acetic acid. Gels were finally 
destained in 10 % glacial acetic acid. 
Membrane Protein Estimation; The membrane protein were estimated as desc-
ribed by Haest et al. (1978) using the procedure of Lowry et al. (1951). 
Red cell membrane was dissolved in 0.2 % SDS (1:1) and suitable aliquots 
of this solution were diluted to 1 ml with distilled water. To this was 
added 5.0 ml of freshly prepared copper reagent (prepared by mixing in 
1:50 ratio of 0.5 % (w/v) copper sulphate in 1 % sodium potassium tarta-
rate and 2.0 % (w/v) sodium carbonate in O.lM sodium hydroxide). After 
incubation at room temperature for 10 min/ 0.5 ml of IN Folin-phenol rea-
gent was added and the tubes were instantly Vortexed. Absorbance of the 
developed blue color was measured after 30 min at 660 nm against a reage-
nt blank in Spectronic 20 spectrophotometer. BSA was used as a reference 
standard. 
Determination of Membrane Sulfhydryl Groups;The overall approach was that 
of Haest et al.(1978). 0.1 ml of freshly prepared ghosts or those treated 
with PHZ were mixed with 0.5 ml of 20 % SDS/ and 0.5 ml of 1 mM solution 
of 5,5'-dithiobis (2-nitrobenzoic acid) was added. The tubes were incuba-
-23-
ted at 37 deg C for 1 he and the absocbance recorded at 412 nm. For the 
determination of sulfhydryl content of protein/ glutathione was used as a 
reference standard. 
Cross-linking of rbc Membrane Protein; The membrane protein cross-linking 
was performed using copper-orthophenanthroline as descrined by Steck 
(1972) and modified by Liu and Palek (1979). 
A stock solution was prepared by dissolving 20 mg of 1/ 10-ortho-
phenanthroline and 5 mg of copper sulphate in 2 ml distilled water. This 
solution was diluted hundred fold to get the working reagent which conta-
ined 50 mM l,10,ortho-phenanthroline and 10 mM copper sulphate. 
0.5 ml of rbc membrane in 0.5 ml of 5 mM Tris-acetate buffer, pH 8.0, 
was mixed with 1 mi working reagent and incubated at 0 deg C for 20 min. 
The supension was diluted by adding 40 ml of 5 inM Tris-acetate buffer, pH 
8.0, to stop the reaction. The oxidized membranes were collected by cent-
rifugation for 30 min at 15,000 g. 
Proteolysis of Human rbc Membrane; Human rbc membrane was prepared by the 
method of Dodge et al. (1963) and cross-linked by copper-orthophenanthro-
iine mixture (Steck, 1972). One volume of the membrane was incubated at 
37 deg C with five volumes of 5mM Tris-acetate buffer, pH 8.0, for 1 hr, 
2 nrs or 3 hrs. The reaction was stopped by adding 40 ml of Tris-acetate 
Duffer, pH 8.0. The ghosts were isolated by centrifugation at 4 deg C for 
20 min. The membranes were dissolved in tracking dye (without beta-merca-
ptoethanoi) in i;l ratio and kept for 5 min in boiling water bath. 
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Charaoterization of the Polymeric Material: The separation gels were cast 
in the glass tubes upto height of 7 cm as described in text. The upper 
gels were prepared by mixing 100 mg agarose/ 0.5 ml of 20 % SDS and 1 ml 
of Deta-mercaptoethanol in 10 ml of distilled water and heated to 40 deg 
C. The mixture was poured on the tops of the already polymerized gels 
(upto 1 cm). 
The electrophoresed unstained gels containing the large molecular 
weight protein adducts were sliced from discs and plac6<3 on the top of 
the new gels and subjected to re-electrophoresis. 
I I I . RESULTS 
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The oxidative stress caused by PHZ in ecythrocytes and other cells 
is well documentejd. In our attempt to understand the nature of oxidative 
damage caused to the erythrocyte membrane by PHZ,the disappearance of the 
sulfhydryl groups were studied.As shown in Fig. II, treatment with PHZ at 
1 mM and 2 mM concentrations resulted in a very significant decrease in 
the membrane sulfhydryl groups. Thirty min. treatment with 1 mM PHZ resu-
lted in the loss of about 60 % membrane sulfhydryl groups as measured by 
DTNB procedure described by Haest et al. (1978). Inccaaae in the incuba-
tion period to 60 min., or use of 2 mM PHZ resulted in only a small furt-
her increase in the loss of membrane sulfhydryl groups. 
As shown in Fig. Ill, treatment of human rbc with concentrations of 
PHZ upto 10 mM resulted in small further decrease in membrane sulfhydryl 
groups. Sixty min., incubation, at all the concentrations tested produced 
slight but consistent enhancement in the further loss of membrane sulfhy-
dryl groups. At very high concentrations of PHZ, however, there was very 
large precipitation of hemoglobin and the preparation of the membranes 
containing small amounts of hemoglobin was difficult. 
As shown in Fig.IV, treatment with 10 mM iodoacetate which is known 
to cause not more than 50% reduction in the rbc sulfhydryl groups, led to 
d small further reduction of membrane sulfhydryl groups (Haest et al., 
1981). It should be mentioned that complete removal of hemoglobin from 
tne erythrocyte membranes was very difficult after PHZ treatment. 
Effect of Phenylhydrazine on Membrane Proteins: The polyacrylamide gel 
electrophoresis performed in presence of SDS of the human rbc membrane 
Fig. II. Effect of Phenylhydrazine on Membrane Sulfhydcyl 
Groups; 
Human erythrocytes were washed three times with 
normal saline. These washed rbcs were treated with 
1 mM or 2 mM of phenylhydrazine for 30 or 60 min., 
at 37 deg C as described in the text. After incu-
bation^ the erythrocytes were hemolyzed and membr-
anes prepared as described earlier in the text. 
Membrane sulfhydryl groups were determined accord-
ing to the method of Haest et al. (1981). The mem-
brane protein was estimated by the method of Lowry 
et ai. (1951). Symbols denote ( • ) 30 min., and 
( A ) 60 min./ incubation at 37 de<3 C. 
lOO! 
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Fig- III. Effect of Phenylhydrazine Concentration on the 
Membrane Sulfhydryl Groups; 
Washed human rbcs were treated with 1-lOmM phenyl-
hydrazine for 30 min.at 37 deg C and the membranes 
were prepared using the method of Dodge et al. 
(1963) as described in text. The membranes were 
separately assayed for sulfhydryl groups. Syml;x)ls 
denote ( • ) 30 min.and ( O ) 60 min. incubation 
at 37 deg C. 
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Fig. IV. Effect of Phenylhydrazine and lodoacetate on rbc 
Membrane 
The membrane of phenyihydrazine-treated rbcs were 
isolated and incubated with or without 10 mM lodo-
acetate at pH 8.0 for 30 min. at 37 deg C, esaeh-
tially following the method of Fischer et al. 
(1978). The reaction mixture was centrlfuged at 
4 deg C and the pellet containing membrane was 
isolated and the sulfhydryl groups and protein co-
ntent determined according to the method of Haest 
et al. (1981) and Lowry et al.(1951) res[)ectively. 
Symbols denote ( • ) Phenyihydrazine-treated for 
30 min. ( jj^ ) Phenyihydrazine-treated for 60 min. 
( o ) Phenyihydrazine-treated 30 min. + 10 niM 
iodoacetate ( A ) Phenyihydrazine-treated 60 min. 
+ 10 mM iodoacetate. 
to 
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yielded pattern similar to that reported by Fairbanks at al.(.1971)/ (Fig. 
V). Treatment with PHZ/ however;resulted in significant formation of agg-
regated material that failed to enter the gel (Fig. VI). In addition, 
significant amount of hemoglobin could be seen in some of the gels. A 
very significant increase in the coomassie blue stainable material in the 
region of band 2.1 and some increase at the 4.1 region was also observed. 
Treatment with 2 mM of PHZ also yielded similar pattern except that the 
bands became more diffuse and there was further increase in the staining 
at 2.1 and 4.1 regions. When the electrophoresis was performed in the 
presence of beta-mercaptoethanol, however, the aggregated material on top 
of the gel almost disappeared, indicating the involvement of disulfide 
bridges in the formation of the aggregate (Fig. VII). 
Characterization of the aggregate: Since the polymeric material formed as 
a result of PHZ treatment could be cleaved by using a sulfhydryl reagent, 
an attempt was made to characterize the polypeptides that constituted 
the aggregated material. For this purpose, the top regions of the unstai-
ned gels containing membranes of the PHZ-treated cells were cut and frag-
mented. Tne small fragments were added on to a second gel and the SDS PAGE 
electrophoresis was performed in presence of beta-mercaptoethanol. As 
shown in Fig.VIII, bands corresponding to spectrin polypeptides and those 
that migrated between 4.2 and 5 region were detected. Only traces of 
coomassie blue stainable material, if any, was detected at the region co-
rresponding to band 3 and other major polypeptides. 
Fig. V. The Polypeptide Composition of Human rbc Membrane 
The human cbcs, were hemolysed by hypotonic 
treatment and washed to completely remove hemoglo-
bin. The ghosts were solubilized in SDS and elec-
trophoresis was performed essentially according to 
the procedure of Fairbanks et al. (1971), except 
that beta-mercaptoethanol was not included. The 
protein bands was numbered according to the nomen-
clature given by Fairbanks et al. (1971). 

Fig. VI. Polypeptide Composition of Phenylhydrazine-Treated 
Erythrocyte Membranes 
The washed human rbcs were treated with 1 nriM (A) 
or 2 mM (B) of phenylhydrazine for 30 and 60 min., 
as described earlier and subjected to polyacryl-
amide gel electrophoresis in absence of beta-merc-
aptoethanol. Gels a control; Gels b phenylhy-
drazine-treated, 30 min.; Gels c phenylhydrazine 
-treated 60 min. 
^ 2 j l ^aggregate 
f 
I 
a b c 
(B) 
Fig. VH. Polypeptide Composition of Phenylhydcazine-Treated 
Erythrocyte Membranes Subjected to SDS-PAGE in 
Presence of Beta-meccaptoethanol. 
Washed human rbcs were treated with 2 mM of pheny-
ihydrazine for 60 min. as described earlier. Poly-
acralamide gel electrophoresis was carried out of 
the membranes prepared in presence of 40 raM beta-
mercaptoethanol (Fairbanks et al.,1971). The elec-
trophoresis buffer also contained 40 inM beta-
mercaptoethanol. Gel A control; Gel B 2 mM pheny-
Ihydrazine-treated, 60 min.; Gel C 2 mM phenylhyd-
razine-treated, 60 min., (electrophoresis was made 
in absence of beta-mercaptoethanol). 
A B C 
Fig.VIII. Determination of the Composition of the High Mole-
cular Weight Cross-linked Adduct: 
Human rbcs were treated with 2 mM phenylhydrazine 
for 60 min./as described earlier. Ghosts were pre-
pared and subjected to SDS-PAGE. One of the two 
parallel gels was stained and the area correspond-
ing to the high molecular weight material at the 
top from the other gel/ was cut and placed on top 
of a fresh gel. Electrophoresis was performed un-
der the standard conditions in presence of SDS and 
40 mM beta-mercaptoethanol and the gels were stai-
ned with coomassie blue. Gel A rbc membrane; Gel 
B high molecular weight aggregate from phenylhyd-
razine-treated membrane. 
A B 
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Proteolysis of the erythrocyte membrane : In order to investigate the po-
ssible contribution of proteolysis under the condition of PHZ treatment, 
rbc membrane were incubated at 37 deg C for various time intervals. As 
shown in Fig.IX, incubation at 37 deg C resulted in very significant deg-
radation of spectrin and other polypeptides. However, no significant for-
mation of the aggregated material could be seen on the top of the gels 
containing membranes incubated at various time intervals.In a preliminary 
study, the membranes were treated with copper-orthophenanthroline mixture 
which is known to cause significant oxidation of membrane sulfhydryl gro-
ups and induce cross-linking. Under such conditions there was cross-link-
ing of spectrin and other polypeptides as well.The membranes treated with 
copper-orthophenanthroline mixture did not, however, show any indication 
of proteolysis after prolonged incubation (data not included). 
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PHZ administration is known to cause the production and accumula-
tion of nydrogen peroxide (Cohen and Hochstein, 1961;1965)/ generation of 
superoxide, hydroxy and phenyl radicals (Hill and Thornalley, 1981). The 
hemolytic effects of PHZ have been attributed to the oxidation of sulfhy-
dryl groups of enzymes, membrane proteins and hemoglobin (Beutler, 1969; 
Neely and Kraus,1972; Jain and Hochstein,1979; Jain and Subramanyan,1976; 
1978).As shown in Fig.II, concentrations of PHZ which are known to decre-
ase in vivo survival of rbcs (Jain and Hochstein, 1980),result in a very 
marked decrease in the membrane sulfhydryl groups. Increasing PHZ concen-
trations from 1 mM to 2 mM or the incubation time from 30 to 60 min. res-
ulted in a small further decrease in the membrane sulfhydryl groups. As 
shown in the Fig.Ill, when the concentrations of PHZ, were increased upto 
10 mM,over 90 % of the membrane sulfhydryl groups disappeard.Haest et al. 
(1981) using a number of sulfhydryl reagents observed that only about 50% 
of the human rbc membrane sulfhydryl groups,are non-reacting to the water 
soluble sulfhydryl reagents. It appears, therefore, that at high concen-
trations,PHZ is capable of reacting with some of these cryptic sulfhydryl 
groups as well. This is presumably related to partial hydrophobic nature 
of PHZ molecule. It is interesting to note that 2mM concentration of PHZ 
resulted in disappearance of about 70 % of the sulfhydryl groups, and 
further treatment of such membranes with iodoacetate results in loss of 
about 80 % of the sulfhydryl groups.This suggests that low concentrations 
of the PHZ treatment may modify sulfhydryl groups which are inaccessible 
to sulfnydryl reagents like iodoacetate, diamide, tetrathionate, etc. 
The polyacryiamide gel electrophoresis of the rbc ghosts obtained 
Fig. IX. Proteolysis of Human cbc Membrane. 
Human rbc membranes prepared by the method of 
Dodge et ai. (1953) as described previously, was 
mixed with five volumes of 5 mM-Tris acetate buff-
er, pH 8.0 and incubated at 37 deg C for various 
time intervals. The membranes were separated by 
centrifugation and subjected to SDS-PAGE as descr-
ibed earlier. Gel A Control; Gel B incubated 1 hr; 
Gel C incubated 2 hrs.; Gel D incubated for 3 hrs. 
A B C D 
IV. DISCUSSION 
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after treatment of rbc with 1 mM and 2 mM of PHZ, yielded patterns which 
are somewhat similar to those observed by Reinhart et al*(1986). As comp-
ared to the results of Reinhart et al. (1986) ghosts obtained in the pre-
sent study retained much smaller amounts of hemoglobin at comparable PHZ 
concentrations. Hemoglobin dimers were also not observed in our studies. 
However,the amount of retained hemoglobin depends on the number of washes 
to which the ghosts were subjected to and this is responsible for the va-
riation observed in the hemoglobin content of ghosts of various prepara-
tions.Since most of the sulfhydryl groups of hemoglobin are also modified 
under these conditions, presence of small amounts of hemoglobin in the 
ghosts may not add significantly to the membrane sulfhydryl groups. In 
agreement with the observations of Reinhart et al. (1986)/ lack of thiol 
reductant resulted in the smearing of bands which became sharper when 
beta-mercaptoethanol was incorporated in the electrophoresis buffer. This 
suggests some degree of formation of intermolecular disulfides. In cont-
rast to the observation of Reinhart et al. (1986)/ we could locate signi-
ficant coomassie blue staining material at the top of the gels, run in 
absence of beta-mercaptoethanol (Fig.VI and VII).This material was marke-
dly decreased when the gels were run in presence of beta-mercaptoethanol. 
Loss of polypeptides corresponding to spectrin in response to PHZ treat-
ment were observed by Jain and Hochstein (1980)/in rat reticulocytes/ who 
could also locate a high molecular weight band presumably representing 
the oligomeric form of spectrin. Reinhart et al. (1986) also observed/ 
decrease in spectrin polypeptides in response to 100 mg/dl PHZ treatment 
in vitrO/although they could not detect the formation of any high molecu-
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lar weight substance. Our studies in Fig. VIII/ show that the polymeric 
material retained on the top in response to PH2 consists mainly of spect-
rin and band 4.5 region. Spectrin bands readily undergo oligomerization 
via S-S bonds in presence of sulfhydryl cross-linking reagents (Haest 
et al./ 1978). It is difficult to characterize the band appearing in the 
4.5 region, which may be proteolyzed band 3 or polypeptide of 4.5 region 
itself. Indeed proteolysis is a serious problem with ghosts exposed to 
higher temperatures and as shown in Fig. IX, there was very significant 
degradation of spectrin and several other polypeptides in ghosts incuba-
ted at 37 deg C. A number of proteases have been studied in the rbc incl-
uding the Ca++ activated protease (Anderson et al., 1977). However, since 
Cd++ is not included in the medium such a protease may not be activated 
to a large extent. We have also observed, in a preliminary study, that 
treatment with another thiol cross-linking reagent, copper-ortho-phenan-
chroline mixture, almost completely prevented the degradation of membrane 
proteins. It has been reported earlier that leupeptin, an inhibitor of 
thiol dependent proteinase, also inhibits calpain the major protease pre-
sent in human rbc membrane (Pontremoli et al., 1984).Specific cleavage of 
minor components cannot be, however, completely ruled out. 
V . SUMMARY 
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The effect of PHZ on the human erythrocyte membrane sulfhydryl gro-
oups was investigated.Treatment of erythrocytes with ImM and 2 mM PHZ for 
30 min, resulted in the loss of 60 % and 65 % membrane sulfhydryl groups 
respectively, as measured by the Ellman's procedure. These concentrations 
of PHZ cause Heinz bodies formation in human erythrocytes. Increasing of 
Che incubation time from 30 to 60 min. resulted in small further loss of 
the membrane sulfhydryl groups. A concentration dependent decrease of the 
memorane sulfhydryl groups was observed upto 10 mM PHZ although the decr-
ease were quite small after 2 mM PHZ. 
Poiyacrylamide gel electrophoresis of human erythrocyte membrane 
proteins treated with 1 mM or 2 mM PHZ indicated the formation of small 
amounts of high molecular weight aggregates that do not enter the gels. 
The polymeric material disappeared when the electrophoresis was performed 
in the presence of beta-mercaptoethanol. Re-electrophoresis of the aggre-
gate in presence of beta-mercaptoethanol indicated the presence of spect-
rin polypeptides as well as a polypeptide migrating in 4.5 region. It 
could not be ascertained whether the latter polypeptide is the product of 
proteolysis of some of the larger polypeptides. Very significant degra-
dation of rbc membrane polypeptides, especially that of spectrin,resulted 
when the membranes were incubated at 37 deg C. Treatment with another 
sulfhydryl crosslinking reagent, copper-orthophenanthroline mixture res-
tricted such proteolysis to a very large extent. 
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FUTURE PLAN 
It is proposed to investigate the following: 
1. The nature of the sulfhydryl group of the human erythrocyte membra-
ne proteins/ that are susceptible/resistant to PHZ treatment will 
be investigated. Membrane will be isolated from the PHZ-treated rbc 
and the proteins will be fractionated either by gel filtration in 
presence of denaturants or by SDS-PAGE.The individual proteins will 
be analyzed for their sulfhydryl content. By comparison with the 
respective untreated samples, the extent of sulfhydryl groups modi-
fied will be determined. With the help of various sulfhydryl reag-
ents, the nature/reactivities of the PHZ resistant sulfhydryl groups 
will be studied. 
2. Heinz bodies will be induced in vivo by injecting appropriate amou-
nts of PHZ in rats/rabbits. Alterations in the membrane proteins 
and sulfhydryl groups will be investigated and compared with those 
of rbcs treated with PHZ _iri vitro. 
3. Effect of i£ vivo and ui vitro treatment with PHZ on the rbc membr-
ane proteolytic activity and Ca++ activated transglutaminase will 
be investigated. 
4. The nature and extent of lipid peroxidation induced by PHZ in vivo 
and in vitro will be investigated and compared. 
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